HomepageCRL • NYSE
add
Charles River Laboratories
Vorige slotkoers
$Â 163,69
Dag-range
$Â 159,65 - $Â 163,00
Jaar-range
$Â 159,65 - $Â 275,00
Beurswaarde
8,29Â mld. USD
Gem. volume
802,66K
Koers/winst
20,24
Dividendrendement
-
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,01Â mld. | -1,64% |
Bedrijfskosten | 219,42Â mln. | 5,38% |
Netto inkomsten | 69,66Â mln. | -20,29% |
Netto winstmarge | 6,90 | -18,92% |
Winst per aandeel | 2,59 | -4,78% |
EBITDA | 236,55Â mln. | -4,13% |
Effectief belastingtarief | 22,96% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 210,17Â mln. | 33,72% |
Totale activa | 8,00Â mld. | 5,22% |
Totale passiva | 4,18Â mld. | -1,88% |
Totaal aandelenvermogen | 3,83 mld. | — |
Uitstaande aandelen | 51,14 mln. | — |
Koers-boekwaardeverhouding | 2,21 | — |
Rendement op activa | 4,65% | — |
Rendement op kapitaal | 5,62% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 69,66Â mln. | -20,29% |
Operationele kasstroom | 251,79Â mln. | 22,56% |
Kasstroom uit beleggingen | -21,32Â mln. | 73,20% |
Kasstroom uit financiering | -207,54Â mln. | -27,43% |
Nettomutatie in liquide middelen | 30,64Â mln. | 170,98% |
Vrije kasstroom | 223,49Â mln. | 120,91% |
Over
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Opgericht
1947
Hoofdvestiging
Website
Werknemers
21.100